SURFACE ONCOLOGY INC (SURF) Stock Analyst Ratings
USA - NASDAQ:SURF - US86877M2098 - Common Stock
1.07 USD
-0.01 (-0.93%)
1.07 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 76% to SURF. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.43. This target is 127.19% above the current price.
SURF was analyzed by 11 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about SURF.
In the previous month the buy percentage consensus was at a similar level.
SURF was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-06-20 | Wedbush | Downgrade | Outperform -> Neutral |
| 2023-06-20 | Baird | Downgrade | Outperform -> Neutral |
| 2023-06-20 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-10 | Wedbush | Reiterate | Outperform |
| 2023-03-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-03 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-08 | HC Wainwright & Co. | Maintains | Buy |
| 2021-05-18 | BTIG | Initiate | Buy |
SURFACE ONCOLOGY INC / SURF FAQ
What do analysts expect the price target to be for SURFACE ONCOLOGY INC (SURF)?
11 analysts have analysed SURF and the average price target is 2.43 USD. This implies a price increase of 127.19% is expected in the next year compared to the current price of 1.07.
What is the consensus rating for SURFACE ONCOLOGY INC (SURF) stock?
The consensus rating for SURFACE ONCOLOGY INC (SURF) is 76.3636 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for SURF stock?
The number of analysts covering SURFACE ONCOLOGY INC (SURF) is 11.